Cargando…
237P Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: A joint analysis of OnCovid and ESMO-CoCARE registries
Autores principales: | Cortellini, A., Dettorre, G., Dafni, U., Aguilar Company, J., Castelo-Branco, L., Lambertini, M., Gennatas, S., Rogado, J., Vinal Lozano, D., Harrington, K.J., Tsourti, Z., Michielin, O.A., Pommeret, F., Brunet Vidal, J.M., Tabernero, J., Pentheroudakis, G., Gennari, A., Peters, S., Romano, E., Pinato, D.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732918/ http://dx.doi.org/10.1016/j.iotech.2022.100226 |
Ejemplares similares
-
Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries
por: Cortellini, Alessio, et al.
Publicado: (2022) -
COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE)
por: Castelo-Branco, L., et al.
Publicado: (2022) -
LBA70 COVID-19 in cancer patients: Update from the joint analysis of ESMO-CoCARE, BSMO, PSMO international databases
por: Romano, E., et al.
Publicado: (2022) -
COVID-19 in cancer patients: update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databases
por: Martin, P., et al.
Publicado: (2023) -
1567MO COVID-19 and cancer: First report of the ESMO international, registry-based, cohort study (ESMO CoCARE)
por: Romano, E., et al.
Publicado: (2021)